Recruiting

A Non-interventional, Post-authorisation Safety Study of Patients Treated with Efgartigimod Alfa

Sponsor:

argenx

Code:

NCT06298565

Conditions

Myasthenia Gravis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

efgartigimod

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information